Quality of life in glaucoma.
Glaucoma
Quality of life
Questionnaire
Vision-related quality of life
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
03
12
2022
accepted:
24
03
2023
revised:
07
03
2023
medline:
23
10
2023
pubmed:
6
4
2023
entrez:
5
4
2023
Statut:
ppublish
Résumé
An essential goal of glaucoma management is to prevent a patient's visual impairment that compromises their health-related quality of life (QOL). The disease itself, in addition to the medical or surgical treatment, can have a large impact on one's life. We aim to briefly review and evaluate aspects of QOL in glaucoma. The PubMed database was utilized for the literature examination of this review. Keywords that were searched included glaucoma, quality of life, vision-related QOL (VRQOL), quality of life questionnaire, and glaucoma therapy. The main topics identified and analyzed during the literature review stages include factors affecting VRQOL, the assessment of VRQOL using questionnaires, QOL in early and severe glaucoma, glaucoma and activities of daily living, glaucoma treatments, and new advances in clinically assessing QOL. The study findings indicate a relationship between the deterioration of visual field and the quality of life. The investigation shows that visual loss can result in a range of daily life challenges, which include compromised mental health status and difficulties with driving, reading, and recognizing people. Glaucoma-induced visual field loss can significantly impact different aspects of patients' life, and several methods exist for evaluating changes in quality of life. Quality of life assessments have their limitations as they are subjective. As potential future steps, we suggest exploring technological advancements such as virtual reality to improve patient care and outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
An essential goal of glaucoma management is to prevent a patient's visual impairment that compromises their health-related quality of life (QOL). The disease itself, in addition to the medical or surgical treatment, can have a large impact on one's life. We aim to briefly review and evaluate aspects of QOL in glaucoma.
METHODS
METHODS
The PubMed database was utilized for the literature examination of this review. Keywords that were searched included glaucoma, quality of life, vision-related QOL (VRQOL), quality of life questionnaire, and glaucoma therapy.
RESULTS
RESULTS
The main topics identified and analyzed during the literature review stages include factors affecting VRQOL, the assessment of VRQOL using questionnaires, QOL in early and severe glaucoma, glaucoma and activities of daily living, glaucoma treatments, and new advances in clinically assessing QOL. The study findings indicate a relationship between the deterioration of visual field and the quality of life. The investigation shows that visual loss can result in a range of daily life challenges, which include compromised mental health status and difficulties with driving, reading, and recognizing people.
CONCLUSION
CONCLUSIONS
Glaucoma-induced visual field loss can significantly impact different aspects of patients' life, and several methods exist for evaluating changes in quality of life. Quality of life assessments have their limitations as they are subjective. As potential future steps, we suggest exploring technological advancements such as virtual reality to improve patient care and outcomes.
Identifiants
pubmed: 37017741
doi: 10.1007/s00417-023-06050-z
pii: 10.1007/s00417-023-06050-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3023-3030Subventions
Organisme : NEI NIH HHS
ID : R01EY029058
Pays : United States
Organisme : NEI NIH HHS
ID : P30EY022589
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY034148
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY029058
Pays : United States
Organisme : NEI NIH HHS
ID : P30EY022589
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY034148
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Weinreb RN, Leung CK, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, Martin KR (2016) Primary open-angle glaucoma. Nat Rev Dis Primers 2:16067. https://doi.org/10.1038/nrdp.2016.67
doi: 10.1038/nrdp.2016.67
pubmed: 27654570
Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901–1911. https://doi.org/10.1001/jama.2014.3192
doi: 10.1001/jama.2014.3192
pubmed: 24825645
pmcid: 4523637
Blindness GBD, Vision Impairment C, Vision Loss Expert Group of the Global Burden of Disease S (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9:e144–e160. https://doi.org/10.1016/S2214-109X(20)30489-7
doi: 10.1016/S2214-109X(20)30489-7
Medeiros FA, Lisboa R, Zangwill LM, Liebmann JM, Girkin CA, Bowd C, Weinreb RN (2014) Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma. Ophthalmology 121:100–109. https://doi.org/10.1016/j.ophtha.2013.06.026
doi: 10.1016/j.ophtha.2013.06.026
pubmed: 23948465
(1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 28: 551–558 https://doi.org/10.1017/s0033291798006667
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, National Eye Institute Visual Function Questionnaire Field Test I (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119:1050–1058. https://doi.org/10.1001/archopht.119.7.1050
doi: 10.1001/archopht.119.7.1050
pubmed: 11448327
Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer JR, Wizov SS, Spaeth GL (2010) Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol 17:144–151. https://doi.org/10.3109/09286581003734878
doi: 10.3109/09286581003734878
pubmed: 20455843
Chiang MF (2021) The 2021 National Eye Institute strategic plan-relating vision to health and quality of life. JAMA Ophthalmol 139:1263–1265. https://doi.org/10.1001/jamaophthalmol.2021.4774
doi: 10.1001/jamaophthalmol.2021.4774
pubmed: 34724031
Nirmalan PK, Tielsch JM, Katz J, Thulasiraj RD, Krishnadas R, Ramakrishnan R, Robin AL (2005) Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 46:2308–2312. https://doi.org/10.1167/iovs.04-0830
doi: 10.1167/iovs.04-0830
pubmed: 15980215
Broman AT, Munoz B, Rodriguez J, Sanchez R, Quigley HA, Klein R, Snyder R, West SK (2002) The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci 43:3393–3398
pubmed: 12407148
Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE (2005) Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol 123:807–814. https://doi.org/10.1001/archopht.123.6.807
doi: 10.1001/archopht.123.6.807
pubmed: 15955982
Nutheti R, Shamanna BR, Nirmalan PK, Keeffe JE, Krishnaiah S, Rao GN, Thomas R (2006) Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci 47:4742–4748. https://doi.org/10.1167/iovs.06-0020
doi: 10.1167/iovs.06-0020
pubmed: 17065482
Wu SY, Hennis A, Nemesure B, Leske MC, Barbados Eye Studies G (2008) Impact of glaucoma, lens opacities, and cataract surgery on visual functioning and related quality of life: the Barbados eye studies. Invest Ophthalmol Vis Sci 49:1333–1338. https://doi.org/10.1167/iovs.07-1252
doi: 10.1167/iovs.07-1252
pubmed: 18385046
Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, Li T, Mansberger SL, American Academy of Ophthalmology Preferred Practice Pattern Glaucoma P (2021) Primary open-angle glaucoma preferred practice pattern(R). Ophthalmology 128:P71–P150. https://doi.org/10.1016/j.ophtha.2020.10.022
doi: 10.1016/j.ophtha.2020.10.022
pubmed: 34933745
Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS (2009) Glaucoma and reading speed: the Salisbury eye evaluation project. Arch Ophthalmol 127:82–87. https://doi.org/10.1001/archophthalmol.2008.523
doi: 10.1001/archophthalmol.2008.523
pubmed: 19139345
pmcid: 2728116
Friedman DS, Freeman E, Munoz B, Jampel HD, West SK (2007) Glaucoma and mobility performance: the Salisbury eye evaluation project. Ophthalmology 114:2232–2237. https://doi.org/10.1016/j.ophtha.2007.02.001
doi: 10.1016/j.ophtha.2007.02.001
pubmed: 17980433
Freeman EE, Munoz B, West SK, Jampel HD, Friedman DS (2008) Glaucoma and quality of life: the Salisbury eye evaluation. Ophthalmology 115:233–238. https://doi.org/10.1016/j.ophtha.2007.04.050
doi: 10.1016/j.ophtha.2007.04.050
pubmed: 17655930
McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R (2008) Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino eye study. Ophthalmology 115:941-948.e941. https://doi.org/10.1016/j.ophtha.2007.08.037
doi: 10.1016/j.ophtha.2007.08.037
pubmed: 17997485
Medeiros FA, Gracitelli CP, Boer ER, Weinreb RN, Zangwill LM, Rosen PN (2015) Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 122:293–301. https://doi.org/10.1016/j.ophtha.2014.08.014
doi: 10.1016/j.ophtha.2014.08.014
pubmed: 25444345
van Gestel A, Webers CA, Beckers HJ, van Dongen MC, Severens JL, Hendrikse F, Schouten JS (2010) The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond) 24:1759–1769. https://doi.org/10.1038/eye.2010.133
doi: 10.1038/eye.2010.133
pubmed: 21057519
Arora KS, Boland MV, Friedman DS, Jefferys JL, West SK, Ramulu PY (2013) The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology 120:2476–2484. https://doi.org/10.1016/j.ophtha.2013.07.020
doi: 10.1016/j.ophtha.2013.07.020
pubmed: 23993358
Man REK, Gan ATL, Fenwick EK, Gupta P, Thakur S, Fang XL, Cheng CY, Wong TY, Lamoureux EL (2021) The differential impact of age on vision-related quality of life across the visual impairment spectrum. Ophthalmology 128:354–363. https://doi.org/10.1016/j.ophtha.2020.07.046
doi: 10.1016/j.ophtha.2020.07.046
pubmed: 32738259
Grisafe DJ, 2nd, McKean-Cowdin R, Burkemper BS, Xu BY, Torres M, Varma R, Multiethnic Ophthalmology Cohorts of California Study G (2022) Visual field loss impacts vision-specific quality of life by race and ethnicity: the multiethnic ophthalmology cohorts of California study. Ophthalmology 129: 668-678. https://doi.org/10.1016/j.ophtha.2022.01.001
Sawada H, Yoshino T, Fukuchi T, Abe H (2014) Assessment of the vision-specific quality of life using clustered visual field in glaucoma patients. J Glaucoma 23:81–87. https://doi.org/10.1097/IJG.0b013e318265bbdc
doi: 10.1097/IJG.0b013e318265bbdc
pubmed: 22828009
Abe RY, Diniz-Filho A, Costa VP, Gracitelli CP, Baig S, Medeiros FA (2016) The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma. Ophthalmology 123:552–557. https://doi.org/10.1016/j.ophtha.2015.10.046
doi: 10.1016/j.ophtha.2015.10.046
pubmed: 26704883
Cheng HC, Guo CY, Chen MJ, Ko YC, Huang N, Liu CJ (2015) Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol 133:269–275. https://doi.org/10.1001/jamaophthalmol.2014.4908
doi: 10.1001/jamaophthalmol.2014.4908
pubmed: 25429608
Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, Lee PP (1998) Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227–233. https://doi.org/10.1001/archopht.116.2.227
doi: 10.1001/archopht.116.2.227
pubmed: 9488276
Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 116:1496–1504. https://doi.org/10.1001/archopht.116.11.1496
doi: 10.1001/archopht.116.11.1496
pubmed: 9823352
Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, Sherwood M, Meng K, Mangione CM (1997) Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 115:777–784. https://doi.org/10.1001/archopht.1997.01100150779014
doi: 10.1001/archopht.1997.01100150779014
pubmed: 9194730
Lee BL, Gutierrez P, Gordon M, Wilson MR, Cioffi GA, Ritch R, Sherwood M, Mangione CM (1998) The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol 116:861–866. https://doi.org/10.1001/archopht.116.7.861
doi: 10.1001/archopht.116.7.861
pubmed: 9682698
Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, Legro MW, Diener-West M, Bass EB, Damiano AM et al (1994) The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 112:630–638. https://doi.org/10.1001/archopht.1994.01090170074026
doi: 10.1001/archopht.1994.01090170074026
pubmed: 8185520
Damiano AM, Steinberg EP, Cassard SD, Bass EB, Diener-West M, Legro MW, Tielsch J, Schein OD, Javitt J, Kolb M (1995) Comparison of generic versus disease-specific measures of functional impairment in patients with cataract. Med Care 33:AS120-130
pubmed: 7723440
Cassard SD, Patrick DL, Damiano AM, Legro MW, Tielsch JM, Diener-West M, Schein OD, Javitt JC, Bass EB, Steinberg EP (1995) Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol 113:1508–1513. https://doi.org/10.1001/archopht.1995.01100120038005
doi: 10.1001/archopht.1995.01100120038005
pubmed: 7487617
Parrish RK 2nd, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, Montenegro-Piniella A (1997) Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 115:1447–1455. https://doi.org/10.1001/archopht.1997.01100160617016
doi: 10.1001/archopht.1997.01100160617016
pubmed: 9366678
Sherwood MB, Garcia-Siekavizza A, Meltzer MI, Hebert A, Burns AF, McGorray S (1998) Glaucoma’s impact on quality of life and its relation to clinical indicators. Pilot Study Ophthalmols 105:561–566. https://doi.org/10.1016/S0161-6420(98)93043-3
doi: 10.1016/S0161-6420(98)93043-3
Alqudah A, Mansberger SL, Gardiner SK, Demirel S (2016) Vision-related quality of life in glaucoma suspect or early glaucoma patients. J Glaucoma 25:629–633. https://doi.org/10.1097/IJG.0000000000000445
doi: 10.1097/IJG.0000000000000445
pubmed: 27483331
pmcid: 4975427
Prager AJ, Hood DC, Liebmann JM, De Moraes CG, Al-Aswad LA, Yu Q, Cioffi GA, Blumberg DM (2017) Association of glaucoma-related, optical coherence tomography-measured macular damage with vision-related quality of life. JAMA Ophthalmol 135:783–788. https://doi.org/10.1001/jamaophthalmol.2017.1659
doi: 10.1001/jamaophthalmol.2017.1659
pubmed: 28594977
pmcid: 5710204
Shabana N, Cornilleau-Peres V, Droulez J, Goh JC, Lee GS, Chew PT (2005) Postural stability in primary open angle glaucoma. Clin Exp Ophthalmol 33:264–273. https://doi.org/10.1111/j.1442-9071.2005.01003.x
doi: 10.1111/j.1442-9071.2005.01003.x
pubmed: 15932530
Mihailovic A, Swenor BK, Friedman DS, West SK, Gitlin LN, Ramulu PY (2017) Gait implications of visual field damage from glaucoma. Transl Vis Sci Technol 6:23. https://doi.org/10.1167/tvst.6.3.23
doi: 10.1167/tvst.6.3.23
pubmed: 28660098
pmcid: 5484170
Turano KA, Rubin GS, Quigley HA (1999) Mobility performance in glaucoma. Invest Ophthalmol Vis Sci 40:2803–2809
pubmed: 10549639
Sotimehin AE, Yonge AV, Mihailovic A, West SK, Friedman DS, Gitlin LN, Ramulu PY (2018) Locations, circumstances, and outcomes of falls in patients with glaucoma. Am J Ophthalmol 192:131–141. https://doi.org/10.1016/j.ajo.2018.04.024
doi: 10.1016/j.ajo.2018.04.024
pubmed: 29750950
pmcid: 6064672
Kwon M, Huisingh C, Rhodes LA, McGwin G Jr, Wood JM, Owsley C (2016) Association between glaucoma and at-fault motor vehicle collision involvement among older drivers: a population-based study. Ophthalmology 123:109–116. https://doi.org/10.1016/j.ophtha.2015.08.043
doi: 10.1016/j.ophtha.2015.08.043
pubmed: 26459997
van Landingham SW, Hochberg C, Massof RW, Chan E, Friedman DS, Ramulu PY (2013) Driving patterns in older adults with glaucoma. BMC Ophthalmol 13:4. https://doi.org/10.1186/1471-2415-13-4
doi: 10.1186/1471-2415-13-4
pubmed: 23432845
pmcid: 3598274
Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C (2003) Quality of life in glaucoma and its relationship with visual function. J Glaucoma 12:139–150. https://doi.org/10.1097/00061198-200304000-00009
doi: 10.1097/00061198-200304000-00009
pubmed: 12671469
Bhargava JS, Patel B, Foss AJ, Avery AJ, King AJ (2006) Views of glaucoma patients on aspects of their treatment: an assessment of patient preference by conjoint analysis. Invest Ophthalmol Vis Sci 47:2885–2888. https://doi.org/10.1167/iovs.05-1244
doi: 10.1167/iovs.05-1244
pubmed: 16799029
McGwin G Jr, Mays A, Joiner W, Decarlo DK, McNeal S, Owsley C (2004) Is glaucoma associated with motor vehicle collision involvement and driving avoidance? Invest Ophthalmol Vis Sci 45:3934–3939. https://doi.org/10.1167/iovs.04-0524
doi: 10.1167/iovs.04-0524
pubmed: 15505039
Haymes SA, Leblanc RP, Nicolela MT, Chiasson LA, Chauhan BC (2007) Risk of falls and motor vehicle collisions in glaucoma. Invest Ophthalmol Vis Sci 48:1149–1155. https://doi.org/10.1167/iovs.06-0886
doi: 10.1167/iovs.06-0886
pubmed: 17325158
Hu PS, Trumble DA, Foley DJ, Eberhard JW, Wallace RB (1998) Crash risks of older drivers: a panel data analysis. Accid Anal Prev 30:569–581. https://doi.org/10.1016/s0001-4575(98)00019-0
doi: 10.1016/s0001-4575(98)00019-0
pubmed: 9678211
Tanabe S, Yuki K, Ozeki N, Shiba D, Abe T, Kouyama K, Tsubota K (2011) The association between primary open-angle glaucoma and motor vehicle collisions. Invest Ophthalmol Vis Sci 52:4177–4181. https://doi.org/10.1167/iovs.10-6264
doi: 10.1167/iovs.10-6264
pubmed: 21447677
Nguyen AM, van Landingham SW, Massof RW, Rubin GS, Ramulu PY (2014) Reading ability and reading engagement in older adults with glaucoma. Invest Ophthalmol Vis Sci 55:5284–5290. https://doi.org/10.1167/iovs.14-14138
doi: 10.1167/iovs.14-14138
pubmed: 25052992
pmcid: 4142770
Burton R, Saunders LJ, Crabb DP (2015) Areas of the visual field important during reading in patients with glaucoma. Jpn J Ophthalmol 59:94–102. https://doi.org/10.1007/s10384-014-0359-8
doi: 10.1007/s10384-014-0359-8
pubmed: 25539625
Glen FC, Crabb DP, Smith ND, Burton R, Garway-Heath DF (2012) Do patients with glaucoma have difficulty recognizing faces? Invest Ophthalmol Vis Sci 53:3629–3637. https://doi.org/10.1167/iovs.11-8538
doi: 10.1167/iovs.11-8538
pubmed: 22511628
Skalicky S, Goldberg I (2008) Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 17:546–551. https://doi.org/10.1097/IJG.0b013e318163bdd1
doi: 10.1097/IJG.0b013e318163bdd1
pubmed: 18854731
Zhang X, Olson DJ, Le P, Lin FC, Fleischman D, Davis RM (2017) The association between glaucoma, anxiety, and depression in a large population. Am J Ophthalmol 183:37–41. https://doi.org/10.1016/j.ajo.2017.07.021
doi: 10.1016/j.ajo.2017.07.021
pubmed: 28760639
Hugues FC, Le Jeunne C (1993) Systemic and local tolerability of ophthalmic drug formulations. An update Drug Saf 8:365–380. https://doi.org/10.2165/00002018-199308050-00004
doi: 10.2165/00002018-199308050-00004
pubmed: 8099291
Guldvog B (1999) Can patient satisfaction improve health among patients with angina pectoris? Int J Qual Health Care 11:233–240. https://doi.org/10.1093/intqhc/11.3.233
doi: 10.1093/intqhc/11.3.233
pubmed: 10435845
Donabedian A (1988) The quality of care. How can it be assessed? JAMA 260:1743–1748. https://doi.org/10.1001/jama.260.12.1743
doi: 10.1001/jama.260.12.1743
pubmed: 3045356
Marquis MS, Davies AR, Ware JE Jr (1983) Patient satisfaction and change in medical care provider: a longitudinal study. Med Care 21:821–829. https://doi.org/10.1097/00005650-198308000-00006
doi: 10.1097/00005650-198308000-00006
pubmed: 6888031
Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW (2003) Compliance barriers in glaucoma: a systematic classification. J Glaucoma 12:393–398. https://doi.org/10.1097/00061198-200310000-00001
doi: 10.1097/00061198-200310000-00001
pubmed: 14520147
Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB (2003) Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 121:540–546. https://doi.org/10.1001/archopht.121.4.540
doi: 10.1001/archopht.121.4.540
pubmed: 12695251
Balkrishnan R, Bond JB, Byerly WG, Camacho FT, Anderson RT (2003) Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. Am J Geriatr Pharmacother 1:75–81. https://doi.org/10.1016/s1543-5946(03)90003-1
doi: 10.1016/s1543-5946(03)90003-1
pubmed: 15555469
Naito T, Namiguchi K, Yoshikawa K, Miyamoto K, Mizoue S, Kawashima Y, Shiraishi A, Shiraga F (2017) Factors affecting eye drop instillation in glaucoma patients with visual field defect. PLoS One 12:e0185874. https://doi.org/10.1371/journal.pone.0185874
doi: 10.1371/journal.pone.0185874
pubmed: 29023521
pmcid: 5638255
Guedes RA, Guedes VM, Freitas SM, Chaoubah A (2013) Quality of life of medically versus surgically treated glaucoma patients. J Glaucoma 22:369–373. https://doi.org/10.1097/IJG.0b013e31824ceb8b
doi: 10.1097/IJG.0b013e31824ceb8b
pubmed: 22407390
Katz LJ, Erb C, Carceller GA, Fea AM, Voskanyan L, Wells JM, Giamporcaro JE (2015) Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol 9:2313–2320. https://doi.org/10.2147/OPTH.S96695
doi: 10.2147/OPTH.S96695
pubmed: 26715834
pmcid: 4686332
Perez-Torregrosa VT, Olate-Perez A, Cerda-Ibanez M, Gargallo-Benedicto A, Osorio-Alayo V, Barreiro-Rego A, Duch-Samper A (2016) Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol 91:415–421. https://doi.org/10.1016/j.oftal.2016.02.006
doi: 10.1016/j.oftal.2016.02.006
pubmed: 26995503
Samuelson TW, Singh IP, Williamson BK, Falvey H, Lee WC, Odom D, McSorley D, Katz LJ (2021) Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject(R) pivotal trial. Am J Ophthalmol 229:220–229. https://doi.org/10.1016/j.ajo.2021.03.007
doi: 10.1016/j.ajo.2021.03.007
pubmed: 33737036
Lam AKN, To E, Weinreb RN, Yu M, Mak H, Lai G, Chiu V, Wu K, Zhang X, Cheng TPH, Guo PY, Leung CKS (2020) Use of virtual reality simulation to identify vision-related disability in patients with glaucoma. JAMA Ophthalmol 138:490–498. https://doi.org/10.1001/jamaophthalmol.2020.0392
doi: 10.1001/jamaophthalmol.2020.0392
pubmed: 32191274
pmcid: 7225912
Bennett CR, Bex PJ, Bauer CM, Merabet LB (2019) The assessment of visual function and functional vision. Semin Pediatr Neurol 31:30–40. https://doi.org/10.1016/j.spen.2019.05.006
doi: 10.1016/j.spen.2019.05.006
pubmed: 31548022
pmcid: 6761988
Colenbrander A (2005) Visual functions and functional vision International Congress Series. Elsevier, 482–486
Fenwick EK, Roldan AM, Halawa OA, Meshkin RS, Zebardast N, Popov V, Lis P, Friedman DS, Lamoureux EL (2022) Implementation of an online glaucoma-specific quality of life computerized adaptive test system in a US Glaucoma Hospital. Transl Vis Sci Technol 11:24. https://doi.org/10.1167/tvst.11.2.24
doi: 10.1167/tvst.11.2.24
pubmed: 35171226
pmcid: 8857615
Waisbourd M, Parker S, Ekici F, Martinez P, Murphy R, Scully K, Wizov SS, Hark LA, Spaeth GL (2015) A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology. BMC Ophthalmol 15:91. https://doi.org/10.1186/s12886-015-0088-x
doi: 10.1186/s12886-015-0088-x
pubmed: 26231376
pmcid: 4522094
Smeeth L, Fletcher AE (2002) Improving the response rates to questionnaires. BMJ 324:1168–1169. https://doi.org/10.1136/bmj.324.7347.1168
doi: 10.1136/bmj.324.7347.1168
pubmed: 12016167
pmcid: 1123146
Nakash RA, Hutton JL, Jorstad-Stein EC, Gates S, Lamb SE (2006) Maximising response to postal questionnaires–a systematic review of randomised trials in health research. BMC Med Res Methodol 6:5. https://doi.org/10.1186/1471-2288-6-5
doi: 10.1186/1471-2288-6-5
pubmed: 16504090
pmcid: 1421421
Teresi JA (2006) Different approaches to differential item functioning in health applications. Advantages, disadvantages and some neglected topics. Med Care 44:S152-170. https://doi.org/10.1097/01.mlr.0000245142.74628.ab
doi: 10.1097/01.mlr.0000245142.74628.ab
pubmed: 17060822
Owsley C, McGwin G Jr (2004) Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology 111:2259–2264. https://doi.org/10.1016/j.ophtha.2004.06.026
doi: 10.1016/j.ophtha.2004.06.026
pubmed: 15582083